Advertisement

Annals of Surgical Oncology

, Volume 11, Issue 4, pp 399–406 | Cite as

Heat Shock Protein 70 Is Induced in Mouse Human Colon Tumor Xenografts After Sublethal Radiofrequency Ablation

  • Weng-Lang Yang
  • Deepak G. Nair
  • Ryouji Makizumi
  • George Gallos
  • Xuemei Ye
  • Rohit R. Sharma
  • T. S. RavikumarEmail author
Original Articles

Abstract

Background: Radiofrequency ablation (RFA) destroys tumor cells by generating high temperatures through ionic vibration. Tumor recurrence may be a direct function of sublethal temperature. Further, a set of proteins called heat shock proteins (HSPs) can be synthesized under heat stress to facilitate recovery of tumor cells from heat damage.

Methods: Subcutaneous xenografts were induced in nude mice by injection with HT29 human colon cancer cells. The tumors were exposed surgically and subjected to RFA. The tumors were randomly assigned to achieve a target tumor temperature of 42°C, 45°C, or 50°C. Total RNA and cell lysates were isolated from tumor tissues and subjected to reverse transcription-polymerase chain reaction and Western blot analyses, respectively, at various time points after treatments for assessing HSP expression. For in vitro experiments, HT29 cells were subjected to variable temperatures, and HSP expression was assayed.

Results: During a 50-day follow-up, the recurrence rates were 0% at 50°C, 30% at 45°C, and 100% at 42°C. The messenger RNA and protein levels of HSP90 and HSP27 remained unchanged after RFA at 45°C; however, HSP70 was induced at 4 and 10 hours after RFA. In vitro HT29 culture cells subjected to a heated water bath exhibited a cellular sensitivity to heat and change of HSP expression similar to those in tumor xenografts subjected to RFA.

Conclusions: Our data establish the requisite heat parameters during RFA for human colon tumors in vitro and in vivo. Because HSP70 plays an important role in protecting cell death from a variety of stresses, HSP70 could be a potential target for enhancing the efficacy of RFA.

Key Words:

Radiofrequency ablation Colon cancer Hyperthermia Heat shock protein 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

REFERENCES

  1. 1.
    Fong Y. Surgical therapy of hepatic colorectal metastasis. CA Cancer J Clin 1999; 49: 231–55.PubMedCrossRefGoogle Scholar
  2. 2.
    Yoon SS, Tanabe KK. Surgical treatment and other regional treatments for colorectal cancer liver metastases. Oncologist 1999; 4: 197–208.PubMedGoogle Scholar
  3. 3.
    Stangl R, Altendorf-Hofmann A, Charnley RM, Scheele J. Factors influencing the natural history of colorectal liver metastases. Lancet 1994; 343: 1405–10.PubMedCrossRefGoogle Scholar
  4. 4.
    Fong Y, Cohen AM, Fortner JG, et al. Liver resection for colorectal metastases. J Clin Oncol 1997; 15: 938–46.PubMedGoogle Scholar
  5. 5.
    Cady B, Jenkins RL, Steele GD Jr, et al. Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome. Ann Surg 1998; 227: 566–71.PubMedCrossRefGoogle Scholar
  6. 6.
    Siperstein A, Garland A, Engle K, et al. Laparoscopic radiofrequency ablation of primary and metastatic liver tumors. Technical considerations. Surg Endosc 2000; 14: 400–5.PubMedCrossRefGoogle Scholar
  7. 7.
    Goldberg SN. Radiofrequency tumor ablation: principles and techniques. Eur J Ultrasound 2001; 13: 129–47.PubMedCrossRefGoogle Scholar
  8. 8.
    Dickson JA, Calderwood SK. Temperature range and selective sensitivity of tumors to hyperthermia: a critical review. Ann N Y Acad Sci 1980; 335: 180–205.PubMedCrossRefGoogle Scholar
  9. 9.
    Goldberg SN, Hahn PF, Tanabe KK, et al. Percutaneous radiofrequency tissue ablation: does perfusion-mediated tissue cooling limit coagulation necrosis? J Vasc Interv Radiol 1998; 9: 101–11.PubMedCrossRefGoogle Scholar
  10. 10.
    Bleicher RJ, Allegra DP, Nora DT, Wood TF, Foshag LJ, Bilchik AJ. Radiofrequency ablation in 447 complex unresectable liver tumors: lessons learned. Ann Surg Oncol 2003; 10: 52–8.PubMedCrossRefGoogle Scholar
  11. 11.
    Lindquist S, Craig EA. The heat shock protein. Annu Rev Genet 1988; 22: 631–77.PubMedCrossRefGoogle Scholar
  12. 12.
    Georgopoulos C, Welch WJ. Role of the major heat shock proteins as molecular chaperones. Annu Rev Cell Biol 1993; 9: 601–34.PubMedCrossRefGoogle Scholar
  13. 13.
    Arrigo AP. Small stress proteins: chaperones that act as regulators of intracellular redox state and programmed cell death. Biol Chem 1998; 379: 19–26.PubMedGoogle Scholar
  14. 14.
    Jaattela M. Escaping cell death: survival proteins in cancer. Exp Cell Res 1999; 248: 30–43.PubMedCrossRefGoogle Scholar
  15. 15.
    Yang WL, Yang-Biggs G, Wu Y, et al. Development of cross-resistance between heat and cisplatin or hydroxyurea treatments in FaDu squamous carcinoma cells. J Surg Res 2003; 111: 143–51.PubMedCrossRefGoogle Scholar
  16. 16.
    Mirza AN, Fornage BD, Sneige N, et al. Radiofrequency ablation of solid tumors. Cancer J 2001; 7: 95–102.PubMedGoogle Scholar
  17. 17.
    Machi J, Uchida S, Sumida K, et al. Ultrasound-guided radiofrequency thermal ablation of liver tumors: percutaneous, laparoscopic, and open surgical approaches. J Gastrointest Surg 2001; 5: 477–89.PubMedCrossRefGoogle Scholar
  18. 18.
    Llovet JM, Vilana R, Bru C, et al. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 2001; 33: 1124–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Kuvshinoff BW, Ota DM. Radiofrequency ablation of liver tumors: influence of technique and tumor size. Surgery 2002; 132: 605–12.PubMedCrossRefGoogle Scholar
  20. 20.
    Li GC, Werb Z. Correlation between synthesis of heat shock proteins and development of thermotolerance in Chinese hamster fibroblasts. Proc Natl Acad Sci U S A 1982; 79: 3218–22.PubMedCrossRefGoogle Scholar
  21. 21.
    Elia G, De Marco A, Rossi A, Santoro MG. Inhibition of HSP70 expression by calcium ionophore A23187 in human cells. An effect independent of the acquisition of DNA-binding activity by the heat shock transcription factor. J Biol Chem 1996; 271: 16111–8.PubMedCrossRefGoogle Scholar
  22. 22.
    Nollen EA, Brunsting JF, Roelofsen H, Weber LA, Kampinga HH. In vivo chaperone activity of heat shock protein 70 and thermotolerance. Mol Cell Biol 1999; 19: 2069–79.PubMedGoogle Scholar
  23. 23.
    Mosser DD, Caron AW, Bourget L, Denis-Larose C, Massie B. Role of the human heat shock protein hsp70 in protection against stress-induced apoptosis. Mol Cell Biol 1997; 17: 5317–27.PubMedGoogle Scholar
  24. 24.
    Garrido C, Gurbuxani S, Ravagnan L, Kroemer G. Heat shock proteins: endogenous modulators of apoptotic cell death. Biochem Biophys Res Commun 2001; 286: 433–42.PubMedCrossRefGoogle Scholar
  25. 25.
    Sliutz G, Karlseder J, Tempfer C, Orel L, Holzer G, Simon MM. Drug resistance against gemcitabine and topotecan mediated by constitutive hsp70 overexpression in vitro: implication of quercetin as sensitiser in chemotherapy. Br J Cancer 1996; 74: 172–7.PubMedGoogle Scholar
  26. 26.
    Abe T, Gotoh S, Higashi K. Higher induction of heat shock protein 72 by heat stress in cisplatin-resistant than in cisplatin-sensitive cancer cells. Biochim Biophys Acta 1999; 1445: 123–33.PubMedGoogle Scholar
  27. 27.
    Roigas J, Wallen ES, Loening SA, Moseley PL. Effects of combined treatment of chemotherapeutics and hyperthermia on survival and the regulation of heat shock proteins in Dunning R3327 prostate carcinoma cells. Prostate 1998; 34: 195–202.PubMedCrossRefGoogle Scholar
  28. 28.
    Ciocca DR, Clark GM, Tandon AK, Fuqua SA, Welch WJ, McGuire WL. Heat shock protein hsp70 in patients with axillary lymph node-negative breast cancer: prognostic implications. J Natl Cancer Inst 1993; 85: 570–4.PubMedCrossRefGoogle Scholar
  29. 29.
    Santarosa M, Favaro D, Quaia M, Galligioni E. Expression of heat shock protein 72 in renal cell carcinoma: possible role and prognostic implications in cancer patients. Eur J Cancer 1997; 33: 873–7.PubMedCrossRefGoogle Scholar

Copyright information

© The Society of Surgical Oncology, Inc. 2004

Authors and Affiliations

  • Weng-Lang Yang
    • 1
  • Deepak G. Nair
    • 1
  • Ryouji Makizumi
    • 1
  • George Gallos
    • 1
  • Xuemei Ye
    • 1
  • Rohit R. Sharma
    • 1
  • T. S. Ravikumar
    • 1
    • 2
    Email author
  1. 1.Department of SurgeryAlbert Einstein College of Medicine and Montefiore Medical CenterBronx
  2. 2.Department of SurgeryAlbert Einstein College of Medicine/Montefiore Medical CenterBronx

Personalised recommendations